Zobrazeno 1 - 10
of 338
pro vyhledávání: '"Yoon‐Kyoung Sung"'
Autor:
Yeo-Jin Song, Hyoungyoung Kim, Soo-Kyung Cho, Hye Won Kim, Chaewhi Lim, Eunwoo Nam, Chan-Bum Choi, Tae-Hwan Kim, Jae-Bum Jun, Sang-Cheol Bae, Dae Hyun Yoo, Su Jin Hong, Seung-Jin Yoo, Youkyung Lee, Yoon-Kyoung Sung
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-9 (2024)
Abstract Objectives To determine the risk factors for mortality in Korean patients with rheumatoid arthritis (RA)-associated interstitial lung disease (ILD) in comparison to patients with RA but without ILD (RA-nonILD). Methods Data were extracted fr
Externí odkaz:
https://doaj.org/article/dd1fdee8005f4a759cec7700c237fba6
Publikováno v:
The Korean Journal of Internal Medicine, Vol 39, Iss 4, Pp 680-690 (2024)
Background To evaluate the effectiveness of Korean Red Ginseng (KRG) in managing fatigue in Korean patients with rheumatic diseases Methods Patients were randomly assigned to KRG (2 g/day, n = 60) or placebo (n = 60) groups for 12 weeks of blind phas
Externí odkaz:
https://doaj.org/article/d392fed7eaaf471087af576967c994a8
Autor:
Soojin Cha, So-Young Bang, Young Bin Joo, Soo-Kyung Cho, Chan-Bum Choi, Yoon-Kyoung Sung, Tae-Hwan Kim, Jae-Bum Jun, Dae Hyun Yoo, Hye-Soon Lee, Sang-Cheol Bae
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-6 (2024)
Abstract The strongest genetic risk factor for rheumatoid arthritis (RA) has been known as HLA-DRB1 based on amino acid positions 11, 71, and 74. This study analyzed the association between specific HLA-DRB1 locus and treatment response to abatacept
Externí odkaz:
https://doaj.org/article/56dbbfa27ce04fa4b6373d537037703d
Autor:
Jung-Yong Han, Soo-Kyung Cho, Hyoungyoung Kim, Yena Jeon, Gaeun Kang, Sun-Young Jung, Eun Jin Jang, Yoon-Kyoung Sung
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract To determine the increased risk of major adverse cardiovascular events (MACE) in patients with systemic lupus erythematosus (SLE) compared to the general population in Korea. Using data from the National Health Insurance Service database spa
Externí odkaz:
https://doaj.org/article/b548a6e670cd4b209376424273641ca5
Autor:
Soo-Kyung Cho, Hyoungyoung Kim, Yeo-Jin Song, Hye Won Kim, Eunwoo Nam, Shin-Seok Lee, Hye-Soon Lee, Sung-Hoon Park, Yeon-Ah Lee, Min-Chan Park, Sung Hae Chang, Hyoun-Ah Kim, Seung-Ki Kwok, Hae-Rim Kim, Hyun-Sook Kim, Bo Young Yoon, Wan-Sik Uhm, Yong-Gil Kim, Jae Hoon Kim, Jisoo Lee, Jeongim Choi, Yoon-Kyoung Sung
Publikováno v:
The Korean Journal of Internal Medicine, Vol 38, Iss 4, Pp 546-556 (2023)
Background/Aims We aimed to compare the effectiveness and safety of Janus kinase inhibitors (JAKi) vs. biologic disease-modifying antirheumatic drugs (bDMARD) in Korean patients with rheumatoid arthritis (RA) who had an inadequate response to convent
Externí odkaz:
https://doaj.org/article/0e41d71ea0a04bb9afb3769fa1a3f1bb
Autor:
Sun-Young Jung, Yoon-Kyoung Sung, Soo-Kyung Cho, Dae Hyun Yoo, Yeo-Jin Song, Eunwoo Nam, Yu-Seon Jung, Jihyun Keum
Publikováno v:
RMD Open, Vol 10, Iss 1 (2024)
Objectives We aimed to investigate medication utilisation trends during pregnancy and identify factors associated with adverse pregnancy outcomes (APOs) in patients with rheumatoid arthritis (RA).Methods Female patients with RA aged 20–50 years wer
Externí odkaz:
https://doaj.org/article/8efa79b6a4fa43499118e68acadb7934
Autor:
Yeo-Jin Song, Soo-Kyung Cho, Hyoungyoung Kim, Hye Won Kim, Eunwoo Nam, Ja-Young Jeon, Hyun-Jeong Yoo, Chan-Bum Choi, Tae-Hwan Kim, Jae-Bum Jun, Sang-Cheol Bae, Dae Hyun Yoo, Yoon-Kyoung Sung
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract We aimed to determine the risk of herpes zoster (HZ) in Korean rheumatoid arthritis (RA) patients on tofacitinib compared with tumor necrosis factor inhibitor (TNFi) treatment. From the prospective cohorts of RA patients who started tofaciti
Externí odkaz:
https://doaj.org/article/3ede99af3e934fd1bc67ae42a87c8b64
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract This study identified trends in hydroxychloroquine (HCQ) prescription and retinopathy screening in patients with systemic lupus erythematosus (SLE) according to clinical practice guidelines to minimise the risk of HCQ retinopathy. We used da
Externí odkaz:
https://doaj.org/article/c8db82d8c9484c48bdc49dc6b458f962
Autor:
Hyoungyoung Kim, Soo-Kyung Cho, Yeo-Jin Song, Juyeon Kang, Seung-A Jeong, Hye Won Kim, Chan-Bum Choi, Tae-Hwan Kim, Jae-Bum Jun, Sang-Cheol Bae, Dae-Hyun Yoo, Hyun Lee, Dong Won Park, Jang Won Sohn, Ho Joo Yoon, Su Jin Hong, Seung-Jin Yoo, Yo Won Choi, Youkyung Lee, Sang Heon Kim, Yoon-Kyoung Sung
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-9 (2023)
Abstract Background To introduce a prospective cohort for rheumatoid arthritis (RA) patients with interstitial lung disease (ILD) and to identify their clinical features in comparison with RA patients without ILD. Methods Using a multidisciplinary co
Externí odkaz:
https://doaj.org/article/780f8446e01b4a29b124f54f55775d5d
Autor:
Wan-Hee Yoo, Young Mo Kang, Dong Wook Kim, Eun Ha Kang, Yeon-Ah Lee, Chang-Hee Suh, Yoon-Kyoung Sung, Sang-Hoon Lee, Dong-Ha Gu, Jiwon Lee, Jung-Yoon Choe
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 2, Pp 329-341 (2022)
Abstract Introduction SB4 is the first approved biosimilar of etanercept, a biologic tumor necrosis factor inhibitor, to treat various autoimmune diseases including axial spondylarthritis (axSpA), rheumatoid arthritis (RA), psoriatic arthritis (PsA),
Externí odkaz:
https://doaj.org/article/125870e2bd7342b0a5c52d05a62285b0